Human Immunology Biosciences Launches to Lead Clinical Immun

Human Immunology Biosciences Launches to Lead Clinical Immunology into Its Next Chapter with $120 Million Financing

Related Keywords

China , South Korea , Massachusetts , United States , Brian Kotzin , Jaideep Dudani , Paul Berns , Fred Cohen , Mark Murcko , Christina Carlson , Chris Goodnow , Carol Suh , John Davis , Matthew Albert , John Lowe , Kristin Hogquist , Gregg Silverman , Barbara Krebs Pohl , Mark Daly , Travis Murdoch , Rachel Mears , Andrew Luster , Mamdouhas Bobst , Division Of Rheumatology , Langone Health , Garvan Institute Of Medical Research , University Of Minnesota , Head Of Portfolio Development , Department Of Medicine , Head Of Early Clinical Development At Pfizer , Clinical Development , Monograph Capital , Jeito Capital , Human Immunology Biosciences , Bio Chairman , Managing Director , Greater China , Chief Executive Officer , Chief Translational Officer , General Counsel , Chief Business Officer , Senior Vice President , Portfolio Development , Vice President , Monograph Capital Partners , Founding Chief Scientific Officer , Dewpoint Therapeutics , Relay Therapeutics , Scientific Advisory Board , Founding Chief , Translational Genetics Unit , Massachusetts General Hospital , Early Clinical Development , Executive Director , Garvan Institute , Medical Research , Clinical Pharmacology , Associate Director , Nektar Therapeutics , Senior Director , Internal Medicine ,